COFCO Biotech reports citric acid sales plunge in H1 2023

On 26 Aug., COFCO Biotechnology Co., Ltd. (COFCO Biotech) issued its semi-annual report for H1 2023, with a slash in revenue:Revenue of citric acids and the derivatives: USD73.13 million (RMB525.02 million), down by 50.26% YoY, representing 5.64% of ...

Acidity Regulator Quarterly China Report Q3 2023

www.cnchemicals.com